Reported Reactions

Manufacturers

Device manufacturer, as written on reports

Nobel Biocare G Teborg: medical device reports filed with FDA

488,700 reports name it as the manufacturer of the device involved, 2024–2026.

488,700
reports naming it as manufacturer
1.9% of all MAUDE reports
268,296
reports, 12 months to August 2026
220,390 in the 12 months before
0.1%
classified as malfunction
62.3% across all reports
0%
classified as death, as reported
0.9% across all reports

488,700 medical device reports received by FDA give Nobel Biocare G Teborg as the manufacturer of the device involved, 1.9% of the MAUDE database, from April 2024 to August 2026. Manufacturer names are as written on the report; subsidiaries and spelling variants may appear as separate names.

268,296 reports arrived in the 12 months to August 2026, up 22% from 220,390 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (99.9%) and malfunction (0.1%). Manufacturers are required to report events they learn of, so a large manufacturer with many products in use files many reports. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands named most often

BrandDevice typeReportsLatest 12 monthsClassified as death
NobelActive Internal RP 4.3x10mmImplant, endosseous, root-form15,8029,5280%
NobelReplace CC PMC RP 4.3x10mmImplant, endosseous, root-form15,5878,6900%
NobelParallel CC RP 4.3x10mmImplant, endosseous, root-form14,9819,3180%
NobelReplace CC RP 4.3x10mmImplant, endosseous, root-form13,4638,1660%
NobelReplace CC PMC RP 4.3x8mmImplant, endosseous, root-form10,4335,6880%
NobelActive Internal RP 4.3x11.5mmImplant, endosseous, root-form9,4495,7040%
NobelParallel CC RP 4.3x8.5mmImplant, endosseous, root-form8,1735,1500%
NobelReplace CC RP 4.3x8mmImplant, endosseous, root-form8,1414,7960%
NobelReplace CC PMC RP 5.0x8mmImplant, endosseous, root-form8,1184,4140%
NobelReplace CC RP 5.0x10mmImplant, endosseous, root-form7,3744,3590%
NobelParallel CC RP 4.3x11.5mmImplant, endosseous, root-form7,2844,3850%
NobelReplace CC PMC RP 5.0x10mmImplant, endosseous, root-form6,9213,9020%
NobelReplace CC RP 5.0x8mmImplant, endosseous, root-form6,8504,1230%
NobelActive TiUltra RP 4.3x10mmImplant, endosseous, root-form6,6624,0840%
NobelActive Internal RP 4.3x13mmImplant, endosseous, root-form6,6513,7640%
NobelActive Internal RP 4.3x8.5mmImplant, endosseous, root-form6,5433,8520%
NobelActive Internal RP 5.0x10mmImplant, endosseous, root-form6,1303,5690%
NobelParallel CC TiUltra RP 4.3x10mmImplant, endosseous, root-form5,8693,5490%
NobelReplace CC RP 4.3x11.5mmImplant, endosseous, root-form3,5062,6490%
NobelReplace CC PMC RP 4.3x11.5mmImplant, endosseous, root-form3,1492,7870%
NobelParallel CC RP 5.0x10mmImplant, endosseous, root-form2,0813,2240%
NobelParallel CC RP 5.0x8.5mmImplant, endosseous, root-form1,7572,7970%
Unknown ImplantImplant, endosseous, root-form6131,4540%

Brands with a page on this site, ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Device types

Product codeDevice typeReportsShare
DZEImplant, endosseous, root-form488,700100%

Reports by month, five years

037,45974,918Sep 2021: 0Oct 2021: 0Nov 2021: 0Dec 2021: 02022Jan 2022: 0Feb 2022: 0Mar 2022: 0Apr 2022: 0May 2022: 0Jun 2022: 0Jul 2022: 0Aug 2022: 0Sep 2022: 0Oct 2022: 0Nov 2022: 0Dec 2022: 02023Jan 2023: 0Feb 2023: 0Mar 2023: 0Apr 2023: 0May 2023: 0Jun 2023: 0Jul 2023: 0Aug 2023: 0Sep 2023: 0Oct 2023: 0Nov 2023: 0Dec 2023: 02024Jan 2024: 0Feb 2024: 0Mar 2024: 0Apr 2024: 10May 2024: 0Jun 2024: 0Jul 2024: 2Aug 2024: 2Sep 2024: 0Oct 2024: 761Nov 2024: 20,264Dec 2024: 24,3962025Jan 2025: 23,779Feb 2025: 20,016Mar 2025: 22,488Apr 2025: 4,448May 2025: 18Jun 2025: 1,570Jul 2025: 74,918Aug 2025: 27,732Sep 2025: 24,044Oct 2025: 22,647Nov 2025: 23,338Dec 2025: 25,8272026Jan 2026: 21,907Feb 2026: 23,917Mar 2026: 22,927Apr 2026: 23,616May 2026: 23,712Jun 2026: 23,755Jul 2026: 22,045Aug 2026: 10,561

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type

Death0%0
Injury99.9%488,106
Malfunction0.1%594
Other0%0
Not given0%0

Grey bar: all 26,136,888 MAUDE reports. Event type is the filer's classification and is not verified by FDA.

Questions about Nobel Biocare G Teborg reports

How many FDA device reports name Nobel Biocare G Teborg as manufacturer?

488,700 reports through August 2026, 268,296 of them in the latest 12 months.

Which of its brands appear most often?

NobelActive Internal RP 4.3x10mm (15,802), NobelReplace CC PMC RP 4.3x10mm (15,587), NobelParallel CC RP 4.3x10mm (14,981), NobelReplace CC RP 4.3x10mm (13,463) and NobelReplace CC PMC RP 4.3x8mm (10,433).

Which device types does it report on?

implant, endosseous, root-form (100%).

Does a high count say something about the manufacturer?

Not by itself. Manufacturers must file a report for every event they become aware of, so report volume follows the number of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. Manufacturer names are pooled after company suffixes (Inc., LLC, GmbH and similar) are dropped; names that read as a person rather than an organisation are never published. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.